ITMCTR2000003314尚未招募1 期
Randomized double-blind parallel controlled clinical study of tangerine peel enzyme in the treatment of chronic functional constipation
Guangdong Provinc Traditional Chinese Medical Hospital0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. Subjects aged 18-75 years;
- •2. Subjects with the diagnosis of chronic functional constipation;
- •3. Volunteers who are willing to participate in the research and sign informed consent.
排除标准
- •1. Patients taking defecation drugs within 2 weeks before enrollment.
- •2. Patients with constipation caused by organic diseases: intestinal diseases (colon tumor, diverticulum, intestinal stenosis or obstruction, megacolon, colorectal surgery, volvulus, rectocele, rectal prolapse, hemorrhoids, anal fissure, perianal abscess and fistula, levator ani syndrome, spasmodic rectocentelgia);
- •3. Patients with endocrine and metabolic diseases (severe dehydration, diabetes, hypothyroidism, hyperparathyroidism, multiple endocrine adenomas, heavy metal poisoning, hypercalcemia, hyperor hypomagnesemia, hypokalemia, porphyria, chronic kidney disease, uremia);
- •4. Patients with nervous system diseases (autonomic neuropathy, cerebrovascular disease, cognitive impairment or dementia, multiple sclerosis, Parkinson's disease, spinal cord injury);
- •5. Patients with muscle diseases (amyloidosis, dermatomyositis, scleroderma, systemic sclerosis)
- •6. Patients with drug-induced constipation: antidepressants, antiepileptics, antihistamines, anti tremors and paralysis drugs, antipsychotics, antispasmodics, calcium antagonists, diuretics, monoamine oxidase inhibitors, opioids, sympathomimetics, antacids containing aluminum or calcium, calcium, iron, antidiarrheal, non steroidal anti-inflammatory drugs.
- •7. Patients with heart, liver, kidney, hematopoietic system, immune system and other systemic serious diseases.
- •8. Pregnant or lactating women or those who plan to be pregnant during the trial period or their spouses plan to be pregnant.
- •9. Patients with allergic constitution, alcohol allergy, possible allergy to the drug or mental illness.
- •10. Other objects that cannot be cooperated for a long time.
研究者
相似试验
招募中
1 期
Randomized double-blind parallel controlled clinical trail of Chenpi enzyme in the treatment of hyperlipidemiaHyperlipidemiaITMCTR2000003313Guangdong Province Traditional Chinese Medical Hospital
已完成
1 期
A randomized, double-blind, parallel controlled clinical study of tangerine peel enzyme in the treatment of insomnia with deficiency of heart and spleeinsomniaITMCTR2200005639Guangdong Hospital of traditional Chinese Medicine
招募中
Unknown
A Randomized, Double-Blind, Parallel Group Clinical Study To Evaluate Efficacy And Safety Of UO ABG 01 In The Management Of Borderline Cardio Vascular Risk FactorsCTRI/2023/10/058501Xtractiva Life Science Private Limited
进行中（未招募）
1 期
A randomized, double-blind, parallel group clinical trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous mepolizumab (SB240563) (0.55mg/kg, 2.5mg/kg or 10mg/kg) in pediatric subjects with eosinophilic esophagitis, aged 2 to 17 years - Mepolizumab in paediatric eosinophilic oesophagitisEosinophilic oesophagitisEUCTR2005-006074-10-GBGlaxoSmithKline Research & Development Ltd.72
招募中
3 期
Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant AlbendazoleOnchocerciasisPACTR202003567524647Medicines Development for Global Health12,500